Date: June 11-June 12, 2017 Venue: zhejiang, ningboshi

Contact & Consulting

For more Information
you may Contact Polly CHENG
Fax:      86(21)51552421

Please follow us on WeChat:


In recent years, biological drugs IND applications are increasing in China. Domestic leading biopharmaceutical companies in clinical applications have been approved by the CFDA. Some experts predict that by 2020, there will be a new biopharmaceutical listed. Clinical communication and interaction have become increasingly frequent. In order to provide a communication platform for government, enterprise, doctor and etc, Enmore Healthcare is going to hold the 1st BIOPHARMACEUTICAL CLINICAL DEVELOPMENT SUMMIT!

Why attend?

l   Access to the latest information on the clinical development of biopharmaceuticals

l   Discussion on future development of biological drugs

l   Promote the healthy development of biopharmaceutical industry

Event Highlights

Focus on the hotspot of biopharmaceutical clinical

Pay attention to the compliance of clinical progress

Promote exchanges between enterprises, governments and hospitals

Organized by

Media Partner

Supported by